Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Cancer Drug Market By Products & Services(Immunotherapy ,Hormonal therapy, Targeted therapy, Chemotherapy) By Application (Gastrointestinal cancer, Blood cancer, Prostate cancer) - Global Opportunity, Analysis and Industry Forecast, 2018-2023.

 Healthcare and Pharmaceuticals

Report Overview

Global Cancer Drug Market was valued at USD 73.41 Billion in the year 2017. Global Cancer Drug market is further estimated to grow at a CAGR of 7.98% from 2018 to 2023 to reach USD 116.39 Billion by the year 2023. North America region holds the highest market share in 2017 with APAC region is considered as the fastest growing market in the forecasted period. At a country level, the U.S is the biggest market in 2017 and it is projected to grow at a gradual pace in the coming years.

Roche Diagnostics (Switzerland), Celgene (U.S), Johnson & Johnson (U.S) and Novartis (Switzerland) are some of the key manufacturers in the Global Blood Screening market. From all the key players Roche Diagnostics holds the substantial market share because of its better global presence both at production and at an operational level. Rising research and development expenses to cater changing demand of end users, similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years.

Drivers

            Growing incidence and pervasiveness of various types of cancer

            Academic alliances and partnerships

Restrain

            Side-effects of anti-cancer drug therapy

            The high cost of drug development and a threat of failure

Opportunity

            Scientific advancements in treatment methods

            Increasing focus on personalized Anti-cancer medicine

Challenge

            Patent Cliff

The Immunotherapy segment in the global Cancer Drug Market is expected to hold the highest market share during the forecast period. The growth can be attributed to growing areas within oncology R&D, high efficacy and fewer side effects and unique molecular level targeting. On the other hand, Blood Cancer by the application is expected to grow at the highest CAGR during the year 2018-2023. Majorly due to growing number of blood cancer patient and the high cost of drugs used for the treatment of blood cancer.

Key Benefits for Stakeholders

Cancer Drug Manufacturers, Distributors and Retailers

Research and Consulting organization

Technology Standards Organizations, Forums, Alliances and Associations

End-use industries

Regulatory bodies, policy actors, and consumers.

By Products & Services

Immunotherapy (biologics therapy)        

Hormonal therapy         

Targeted therapy          

Chemotherapy  

Others              

By Application

Gastrointestinal cancer  

Blood cancer     

Prostate cancer 

Skin cancer      

Respiratory/lung cancer 

Breast cancer   

Other types of cancers

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

1. Roche Holdings Inc.   

2. Johnson & Johnson    

3. Novartis AG  

4. Celgene        

5. Eli Lilly and Company

6. Pfizer           

7. Celgene Corporation  

8. Sanofi          

9. Merck & Co.  

10. Amgen Inc.

(A brief overview of another 13 companies is also provided) 

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1. Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2. Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3. To avoid bias, we filter the collected data collected from authenticated sources.
  4. GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5. Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6. Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottoms-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Oncology/ Cancer Drug Market by Products & Services

6.1 Immunotherapy (biologics therapy)   

6.2 Hormonal therapy    

6.3 Targeted therapy     

6.4 Chemotherapy         

6.5 Others

7. Oncology/ Cancer Drugs Market by Application

7.1 Gastrointestinal cancer         

7.2 Blood cancer           

7.3 Prostate cancer       

7.4 Skin cancer 

7.5 Respiratory/lung cancer       

7.6 Breast cancer          

7.7 Other Cancers

8. Geographical Analysis

8.1. Introduction

8.2. North America

       8.2.1. U.S.

       8.2.2. Canada

       8.2.3. Mexico

8.3. Europe

       8.3.1. U.K.

       8.3.2. Germany

       8.3.3. France

       8.3.4. RoE

8.4. Asia Pacific

       8.4.1. South Korea

       8.4.2. China

       8.4.3. Japan

       8.4.4. RoAPAC

8.5. RoW

       8.5.1. Latin America

       8.5.2. Middle East and Africa

9. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

9.1 Roche Holdings Inc. 

9.2 Johnson & Johnson   

9.3 Novartis AG 

9.4 Celgene      

9.5 Eli Lilly and Company           

9.6 Pfizer          

9.7 Celgene Corporation

9.8 Sanofi         

9.9 Merck & Co.

9.10 Amgen Inc.

(A brief overview of another 13 companies is also provided) 

11. Competitive Analysis

11.1. Introduction

11.2. Market Positioning of Key Players

11.3 Competitive Strategies Adopted by Leading Players

        11.3.1. Investments & Expansions

        11.3.2. New Product Launches

        11.3.3. Mergers & Acquisitions

        11.3.4. Agreements, Joint Ventures, and Partnerships

12. Appendix

12.1. Questionnaire

12.2. Available Customizations 

12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

 

List of Tables (27 Tables)

1. Cancer drugs market: Market snapshot
2. Drivers of global cancer drugs market: Impact analysis 
3. Restraints of global cancer drugs market: Impact analysis
4. North America cancer drugs market revenue, by Therapy, 2017-2023(USD Billion)
5. North America cancer drugs market revenue, by cancer type, 2017-2023(USD Billion) 
6. U.S. cancer drugs market revenue, by Therapy, 2017-2023(USD Billion)
7. U.S. cancer drugs market revenue, by cancer type, 2017-2023(USD Billion) 
8. Germany cancer drugs market revenue, by Therapy, 2017-2023(USD Billion)
9. Germany cancer drugs market revenue, by cancer type, 2017-2023(USD Billion)
10. France cancer drugs market revenue, by Therapy, 2017-2023(USD Billion) 
11. France cancer drugs market revenue, by cancer type, 2017-2023(USD Billion)
12. UK cancer drugs market revenue, by Therapy, 2017-2023(USD Billion) 
13. UK cancer drugs market revenue, by cancer type, 2017-2023(USD Billion)
14. Asia Pacific cancer drugs market revenue, by Therapy, 2017-2023(USD Billion) 
15. Asia Pacific cancer drugs market revenue, by cancer type, 2017-2023(USD Billion) 
16. China cancer drugs market revenue, by Therapy 2017-2023(USD Billion) 
17. China cancer drugs market revenue, by cancer type 2017-2023(USD Billion) 
18. Japan cancer drugs market revenue, by Therapy, 2017-2023(USD Billion)
19. Japan cancer drugs market revenue, by cancer type, 2017-2023(USD Billion)
20. India cancer drugs market revenue, by Therapy, 2017-2023(USD Billion)
21. India cancer drugs market revenue, by cancer type, 2017-2023(USD Billion)
22. Latin America cancer drugs market revenue, by Therapy, 2017-2023(USD Billion) 
23. Latin America cancer drugs market revenue, by cancer type, 2017-2023(USD Billion) 
24. Brazil cancer drugs market revenue, by Therapy, 2017-2023(USD Billion)
25. Brazil cancer drugs market revenue, by cancer type, 2017-2023(USD Billion)
26. Middle East and Africa cancer drugs market revenue, by Therapy, 2017-2023(USD Billion)
27. Middle East and Africa cancer drugs market revenue, by cancer type, 2017-2023(USD Billion)

 

                        

List of Figures (25 Figures)

1. Market research process
2. Market research methodology
3. Global cancer drugs market revenue, 2017 - 2023(USD Billion) 
4. Porter’s five forces analysis
5. Cancer drugs Market attractiveness analysis, by therapy segment
6. Cancer drugs: Market attractiveness analysis, by cancer type segment
7. Cancer drugs: Market attractiveness analysis, by regional segment
8. Company market share analysis, 2017 
9. Patent trend between 2011 -2017
10. Patent share by company between 2011 - 2017
11. Patent share by region between 2011 - 2017
12. Global cancer drugs market revenue share by Therapy, 2015 and 2023
13. Global Immunotherapy market, 2017-2023 (USD Billion)
14. Global Targeted Therapy market, 2017-2023(USD Billion)
15. Global Chemotherapy market, 2017-2023 (USD Billion)
16. Global Hormone Therapy market, 2017-2023 (USD Billion)
17. Global others market, 2017-2023 (USD Billion)
18. Global cancer drugs market revenue share by cancer type, 2017 and 2023
19. Global cancer drugs market for Breast Cancer, 2017-2023, (USD Billion) 
20. Global cancer drugs market for Blood Cancer, 2017-2023, (USD Billion) 
21. Global cancer drugs market for Gastrointestinal Cancer, 2017-2023, (USD Billion) 
22. Global cancer drugs market for Prostate Cancer, 2017-2023, (USD Billion)
23. Global cancer drugs market for Skin Cancer, 2017-2023, (USD Billion)
24. Global cancer drugs market for Lung Cancer, 2017-2023, (USD Billion)
25. Global cancer drugs market for other cancer type, 2017-2023, (USD Billion)

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports